Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
2003 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
1999
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
1998
Breast cancer
2016 Standout
The history of cancer epigenetics
2004 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy
1999
Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer
2012
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Fertility Preservation in Adult Male Cancer Patients
2007
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
Safety and antitumor activity of recombinant soluble Apo2 ligand
1999 Standout
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
Hormonal suppression for fertility preservation in males and females
2008
Cytokine determinants of viral tropism
2009
Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines
1998
FragmentStore--a comprehensive database of fragments linking metabolites, toxic molecules and drugs
2010
Bisphosphonates in breast cancer
2005
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
2006
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
1999
Paradoxical roles of the immune system during cancer development
2006 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Specificity and mechanism of action of some commonly used protein kinase inhibitors
2000 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
1998
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma
2004
Mitoxantrone
1996
Preservation of Fertility in Patients with Cancer
2009 Standout
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Premature ovarian failure
2007
Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
1994
Mixed Ligand Copper(II) Complexes of N,N-Bis(benzimidazol-2-ylmethyl)amine (BBA) with Diimine Co-Ligands: Efficient Chemical Nuclease and Protease Activities and Cytotoxicity
2012
Transformation of thyroid epithelium is associated with loss of c-kit receptor.
1995
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
2001 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Biology of Gastrointestinal Stromal Tumors
2004 Standout
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
2000
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
Drug Discovery: A Historical Perspective
2000 StandoutScience
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial
2005
High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993
1999 Standout
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer
1999
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
2002
Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer
1999
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
2004
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice
2002 StandoutNobel
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Works of E.D. Kreuser being referenced
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer
2004
Adhesion Receptors in Malignant Transformation and Dissemination of Gastrointestinal Tumors
1996
IL-4 and TNF-? induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells
1996
Combination of Mitoxantrone and Etoposide in the Treatment of Myelodysplastic Syndromes Transformed into Acute Myeloid Leukemia
1994
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
2003
Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma
1994
Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors
1996
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.
1998
Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: An effective second-line regimen
1997
Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment
1990
Reproductive Toxicity with and without LHRHAAdministration During Adjuvant Chemotherapy in Patients with Germ Cell Tumors
1990
Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines.
1992
Combined treatment of metastatic melanoma with interferons and cytotoxic drugs.
1992
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
1996
Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene.
1992